Abel Hall LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Abel Hall LLC’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-8,674	Closed	-$273K	–	933
2026 Q2	$273K	Buy	+8,674	New	+$256K	0.05%	535

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Abel Hall LLC's CPRX Position: Q3 2026 in Review

Abel Hall LLC sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 8,674 shares — an estimated $273K sold.

Abel Hall LLC first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $273K in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

Abel Hall LLC reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Abel Hall LLC sold 8,674 Catalyst Pharmaceutical shares in Q3 2026, an estimated $273K.
Abel Hall LLC first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
Abel Hall LLC's Catalyst Pharmaceutical position peaked at $273K in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.